Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Teladoc Health Sees Q4 GAAP EPS $(0.25)-$(0.10) vs $(0.17) Est; Sees Sales $622.000M-$652.000M vs $634.855M Est

Author: Benzinga Newsdesk | October 29, 2025 03:10pm
Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.25)-$(0.10) vs $(0.17) analyst estimate. sees sales of $622.000 million-$652.000 million vs $634.855 million analyst estimate.

Posted In: TDOC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist